Literature DB >> 10928981

Yersinia enterocolitica invasin protein triggers IL-8 production in epithelial cells via activation of Rel p65-p65 homodimers.

R Schulte1, G A Grassl, S Preger, S Fessele, C A Jacobi, M Schaller, P J Nelson, I B Autenrieth.   

Abstract

Enteropathogenic Yersinia bacteria trigger the production of the proinflammatory chemokine IL-8, an important chemokine for the recruitment of polymorphonuclear leukocytes (PMN). Yersinia is resistant to phagocytosis by PMN, and the recruitment of these cells is thought to be part of a pathogenic strategy of Yersinia to establish infection by allowing the pathogen to gain access to, and disseminate within, host tissue. We report here that Yersinia expressing the outer membrane protein invasin triggers IL-8 production in epithelial cells. The 195 carboxyl-terminal amino acids of invasin when linked to latex beads are sufficient to trigger IL-8 production. By means of IL-8 promoter reporter gene assays and electrophoretic mobility shift assay experiments, the minimal optimal region of the IL-8 promoter responsive to invasin was identified and invasin-responsive control elements were characterized. Invasin-induced activation of the IL-8 promoter was found to be mediated through a previously identified NF-kappaB element. This NF-kappaB binding site preferentially binds Rel p65-p65 homodimers as well as some p50-p65 heterodimers in response to stimulation by invasin. Invasin-induced NF-kappaB activation correlated with degradation of IkappaBalpha and the inhibition of NF-kappaB by specific inhibitors of IkappaB activation blocked invasin-induced IL-8 secretion. Invasin-triggered IL-8 production does not depend on invasin-triggered uptake of bacteria, and is independent of a functional PI3-kinase. This report is the first to demonstrate the molecular basis of IL-8 production triggered by enteropathogenic bacteria. Together, these data elucidate the possible early pathomechanisms operating in Yersinia infection and may have implications for the design of novel therapeutics directed against this enteropathogen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10928981     DOI: 10.1096/fj.14.11.1471

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  19 in total

1.  Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis.

Authors:  Nadine Grosdent; Isabelle Maridonneau-Parini; Marie-Paule Sory; Guy R Cornelis
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

2.  The Yersinia enterocolitica invasin protein promotes major histocompatibility complex class I- and class II-restricted T-cell responses.

Authors:  O T Bühler; C A Wiedig; Y Schmid; G A Grassl; E Bohn; I B Autenrieth
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Induction of interleukin-8 production via nuclear factor-kappaB activation in human intestinal epithelial cells infected with Vibrio vulnificus.

Authors:  B C Lee; S H Kim; S H Choi; T S Kim
Journal:  Immunology       Date:  2005-08       Impact factor: 7.397

4.  Co-expression of the C-terminal domain of Yersinia enterocolitica invasin enhances the efficacy of classical swine-fever-vectored vaccine based on human adenovirus.

Authors:  Helin Li; Pengbo Ning; Zhi Lin; Wulong Liang; Kai Kang; Lei He; Yanming Zhang
Journal:  J Biosci       Date:  2015-03       Impact factor: 1.826

5.  Surface display of N-terminally anchored invasin by Lactobacillus plantarum activates NF-κB in monocytes.

Authors:  Lasse Fredriksen; Charlotte R Kleiveland; Lene T Olsen Hult; Tor Lea; Cathrine S Nygaard; Vincent G H Eijsink; Geir Mathiesen
Journal:  Appl Environ Microbiol       Date:  2012-06-15       Impact factor: 4.792

6.  Yersinia enterocolitica adhesin A induces production of interleukin-8 in epithelial cells.

Authors:  Yvonne Schmid; Guntram A Grassl; Oliver T Bühler; Mikael Skurnik; Ingo B Autenrieth; Erwin Bohn
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

7.  Neisseria meningitidis adhesin NadA targets beta1 integrins: functional similarity to Yersinia invasin.

Authors:  Virginie Nägele; Jürgen Heesemann; Stephanie Schielke; Luisa F Jiménez-Soto; Oliver Kurzai; Nikolaus Ackermann
Journal:  J Biol Chem       Date:  2011-04-06       Impact factor: 5.157

8.  Identification of commensal bacterial strains that modulate Yersinia enterocolitica and dextran sodium sulfate-induced inflammatory responses: implications for the development of probiotics.

Authors:  Julia S Frick; Kerstin Fink; Frauke Kahl; Maria J Niemiec; Matteo Quitadamo; Katrin Schenk; Ingo B Autenrieth
Journal:  Infect Immun       Date:  2007-05-07       Impact factor: 3.441

9.  A bacterial type III secretion-based protein delivery tool for broad applications in cell biology.

Authors:  Simon J Ittig; Christoph Schmutz; Christoph A Kasper; Marlise Amstutz; Alexander Schmidt; Loïc Sauteur; M Alessandra Vigano; Shyan Huey Low; Markus Affolter; Guy R Cornelis; Erich A Nigg; Cécile Arrieumerlou
Journal:  J Cell Biol       Date:  2015-11-23       Impact factor: 10.539

10.  Yersinia enterocolitica targets cells of the innate and adaptive immune system by injection of Yops in a mouse infection model.

Authors:  Martin Köberle; Annegret Klein-Günther; Monika Schütz; Michaela Fritz; Susanne Berchtold; Eva Tolosa; Ingo B Autenrieth; Erwin Bohn
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.